Femasys Finalizes Proxy for Critical Shareholder Vote on Reverse Split and Dilutive Issuances to Avoid Delisting

summarizeSummary

Femasys Inc. has filed its definitive proxy statement, setting the stage for a critical shareholder meeting to vote on a reverse stock split to avoid Nasdaq delisting and to approve the issuance of shares from existing dilutive convertible notes and warrants.

check_boxKey Events

• Special Shareholder Meeting Scheduled

  A special meeting of stockholders is scheduled for April 29, 2026, to vote on critical proposals, following the preliminary proxy statement filed on March 27, 2026.

• Reverse Stock Split Proposed to Avoid Delisting

  Shareholders will vote on a proposal to amend the company's charter to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25. This action is necessary to regain compliance with Nasdaq's minimum bid price rule and avoid delisting, a significant risk for the company.

• Significant Dilution Potential from Reverse Split

  The reverse stock split, while reducing outstanding shares, will not change the total authorized shares (200,000,000). This will substantially increase the number of authorized but unissued shares, creating significant headroom for future dilutive equity financings.

• Approval Sought for Issuance of Dilutive Securities

  The company seeks shareholder approval to issue shares upon conversion of senior secured convertible notes (conversion price $0.73) and exercise of Series A-1 ($0.81), B-1 ($0.92), C-1 ($1.10), and D-1 ($0.58) warrants. This approval is required under Nasdaq rules if anti-dilution or price adjustment provisions result in an effective issuance price below the Nasdaq Minimum Price, and for issuances to participating directors and officers.

auto_awesomeAnalysis

This definitive proxy statement finalizes the details for critical shareholder votes previously announced in a preliminary filing. The company is seeking approval for a reverse stock split, a necessary step to regain Nasdaq compliance and avoid delisting, a risk highlighted in its recent 10-K. While crucial for maintaining listing, the reverse split will also dramatically increase the number of authorized but unissued shares, creating a substantial overhang for future dilutive capital raises. Concurrently, the company is seeking approval to issue shares from existing convertible notes and warrants, which could lead to significant dilution for current shareholders, especially if anti-dilution provisions are triggered due to the low stock price. This approval is vital for the company to honor its past financing agreements and secure its capital structure, but it signals a high potential for further dilution.